Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis
Nso Nso, Damla Mergen, Mashaal Ikram, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 6, pp. 102569-102569
Closed Access | Times Cited: 11

Showing 11 citing articles:

Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals
Matheus Souza, Ivanna Diaz, Lubna Al‐Sharif
Hepatology International (2024) Vol. 18, Iss. 5, pp. 1396-1415
Closed Access | Times Cited: 9
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
Mohamad Jamalinia, Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 5
Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease
Klaudia Nowak, Krzysztof Łupina, Anna Romac, et al.
Annals of Pharmacotherapy (2025)
Closed Access
Lean MASLD and Cardiovascular Disease: A Review
Nachum Lebovics, Gabriel Heering, William H. Frishman, et al.
Cardiology in Review (2025)
Closed Access
From NAFLD to MASLD: what does it mean?
Lampros Chrysavgis, Εvangelos Cholongitas
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 6, pp. 217-221
Closed Access | Times Cited: 4
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification
Kamran Bagheri Lankarani, Mohamad Jamalinia, Fatemeh Zare, et al.
Advances in Therapy (2025)
Closed Access
Lean Metabolic Dysfunction-Associated Steatotic Liver Disease
Chirag S. Desai, Sweta Lohani, Anuj Sharma, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Metabolic dysfunction associated steatotic liver disease in lean patients. Diagnostic and treatment challenges
E. E. Zabotina, Yu. A. Khabarova, N. Yu. Stukova
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 96-109
Closed Access
Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective Cohort Study
Yuan Li, Xiangming Ma, Jianguo Jia, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102573-102573
Closed Access
Mortality, Hepatic Decompensation, and Cardiovascular- and Renal-Related Outcomes in Lean Versus Non-lean Patients Hospitalized With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Chukwunonso Ezeani, Chidiebele Omaliko, Yazan A. Al‐Ajlouni, et al.
Cureus (2024)
Open Access | Times Cited: 1
Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: A pilot meta-analysis
Hritvik Jain, Neha Pervez, Debankur Dey, et al.
Medicine (2024) Vol. 103, Iss. 36, pp. e39499-e39499
Open Access | Times Cited: 1
Cardiometabolic risk reduction at population level: a utopia or a challenge?
Arrigo F.G. Cicero, Federica Fogacci
Internal and Emergency Medicine (2024)
Closed Access
Page 1

Scroll to top